ASMB Assembly Biosciences, Inc. - Common Stock
ASMB Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
ASMB Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
ASMB Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 4 40,0%
- Achat 5 50,0%
- Conserver 1 10,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
4 analystes · 2026-08-16Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.54 | $-0.58 | 0.04% |
| 31 décembre 2025 | $2.48 | $-0.66 | 3.1% |
| 30 septembre 2025 | $-0.72 | $-0.79 | 0.07% |
| 30 juin 2025 | $-1.33 | $-1.39 | 0.06% |
| 31 mars 2025 | $-1.17 | $-1.63 | 0.46% |
| 31 décembre 2024 | $-1.57 | $-2.08 | 0.51% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| R&D Expense | $65M | $56M | $49M | $70M | $69M | $107M | $86M | $73M | $44M | $33M | |
| SG&A Expense | $20M | $18M | $23M | $24M | $29M | $37M | $33M | $35M | $17M | $12M | |
| Operating Expenses | $84M | $74M | $72M | $94M | $139M | $144M | $119M | $108M | $61M | · | |
| Operating Income | $-12M | $-45M | $-65M | $-94M | $-133M | $-65M | $-103M | $-93M | $-52M | $-45M | |
| Other Non-op | $6M | $6M | $3M | $1M | $302.0K | $3M | $4M | $3M | $368.0K | $399.0K | |
| Pretax Income | $-6M | $-40M | $-61M | $-93M | $-132M | $-62M | $-98M | $-90M | $-52M | $-45M | |
| Income Tax | $0 | $330.0K | $33.0K | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Net Income | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| EPS (Basic) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| EPS (Diluted) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| Shares (Basic) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| Shares (Diluted) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| EBITDA | $-12M | $-45M | $-64M | $-94M | $-132M | $-64M | $-102M | $-93M | $-52M | $-45M |
Bilan 25
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $38M | $20M | $52M | $46M | $59M | $47M | $41M | $82M | $29M | |
| Short-term Investments | · | · | · | · | · | · | · | $177M | $38M | $24M | |
| Receivables | $974.0K | $0 | $43.0K | $944.0K | $336.0K | $1M | $3M | $2M | $2M | $0 | |
| Prepaid Expense | $5M | $3M | $3M | $4M | $7M | $7M | $5M | $2M | $898.0K | $611.2K | |
| Current Assets | $255M | $116M | $134M | $97M | $154M | $224M | $283M | $223M | $123M | $54M | |
| PP&E (Net) | $221.0K | $284.0K | $385.0K | $743.0K | $1M | $2M | $2M | $557.0K | $860.0K | $214.7K | |
| PP&E (Gross) | · | · | $595.0K | $2M | $2M | $3M | $3M | $1M | $1M | $409.3K | |
| Accum. Depreciation | · | · | $210.0K | $2M | $1M | $2M | $1M | $1M | $414.0K | $194.6K | |
| Goodwill | · | · | · | · | · | $13M | $13M | $13M | $13M | $13M | |
| Intangibles | · | · | · | · | · | · | · | · | $29M | $29M | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $889.0K | $2M | $6M | $2M | $3M | $340.0K | · | |
| Total Assets | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Accounts Payable | $1M | $585.0K | $461.0K | $2M | $3M | $5M | $2M | $4M | · | · | |
| Accrued Liabilities | $8M | $7M | $6M | $7M | $7M | $12M | $8M | $10M | $6M | $5M | |
| Current Liabilities | $49M | $48M | $39M | $16M | $16M | $24M | $24M | $18M | $13M | $7M | |
| Capital Leases | $2M | $3M | $1M | $101.0K | $3M | $7M | $9M | $0 | · | · | |
| Deferred Tax | · | · | · | · | · | $3M | $3M | $3M | · | · | |
| Total Liabilities | $51M | $86M | $96M | $19M | $22M | $43M | $67M | $57M | $56M | $18M | |
| Common Stock | $16.0K | $7.0K | $5.0K | $4.0K | $48.0K | $34.0K | $32.0K | $25.0K | $20.0K | $17.2K | |
| Paid-in Capital | · | · | · | · | · | · | · | $553M | $365M | $289M | |
| Retained Earnings | $-832M | $-826M | $-786M | $-725M | $-631M | $-502M | $-439M | $-342M | $-251M | $-208M | |
| AOCI | $-41.0K | $-211.0K | $-81.0K | $-803.0K | $-419.0K | $-270.0K | $-201.0K | $-347.0K | $-392.0K | $-600.8K | |
| Stockholders' Equity | $207M | $33M | $41M | $83M | $169M | $241M | $273M | $211M | $113M | $80M | |
| Liabilities + Equity | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Shares Outstanding | 15,855,329 | 7,457,240 | 5,482,752 | 4,074,552 | 48,120,437 | 34,026,680 | 32,558,307 | 25,495,425 | 20,137,974 | 17,246,754 |
Flux de trésorerie 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $129.0K | $129.0K | $450.0K | $498.0K | $466.0K | $691.0K | $494.0K | $643.0K | $219.0K | · | |
| Stock-based Comp | $5M | $3M | $5M | $7M | $5M | $22M | $21M | $28M | $9M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Restructuring | · | · | $0 | $1M | $2M | $4M | $2M | · | · | · | |
| Other Non-cash | $-40M | $-14M | $78M | $2M | $33M | $-23M | $-7M | · | · | · | |
| Operating Cash Flow | $-41M | $-51M | $23M | $-84M | $-93M | $-63M | $-84M | $-65M | $2M | $-35M | |
| CapEx | $66.0K | $28.0K | $255.0K | $102.0K | $3M | $470.0K | $2M | $340.0K | $865.0K | $147.0K | |
| Investing Cash Flow | $-113M | $40M | $-69M | $91M | $27M | $68M | $-50M | $-135M | $-16M | $36M | |
| Stock Issued | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | $155M | $65M | · | |
| Net Stock Activity | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | · | · | · | |
| Financing Cash Flow | $175M | $29M | $14M | $614.0K | $53M | $8M | $140M | $160M | $67M | $153.0K | |
| Net Change in Cash | $20M | $19M | $-33M | $7M | $-14M | $13M | $5M | $-41M | $53M | $1M | |
| Taxes Paid | · | $400.0K | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-41M | $-51M | $22M | $-85M | $-96M | $-63M | $-86M | $-65M | $995.5K | $-35M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -16.8% | -159.3% | -902.5% | · | -2121.7% | -81.9% | -643.4% | -626.4% | · | · | |
| Net Margin | -8.5% | -140.9% | -854.8% | · | -2076.3% | -78.6% | -611.6% | -613.0% | · | · | |
| Pretax Margin | -8.5% | -139.7% | -854.3% | · | -2116.8% | -78.6% | -616.5% | -605.6% | · | · | |
| EBITDA Margin | -16.6% | -158.8% | -896.2% | · | -2114.2% | -81.0% | -640.4% | -626.4% | · | · | |
| ROA | -3.2% | -31.4% | -51.3% | -63.6% | -54.8% | -20.0% | -32.1% | -41.5% | -32.0% | -38.2% | |
| ROE | -5.5% | -135.4% | -147.9% | -100.6% | -66.0% | -24.3% | -45.4% | -41.2% | -44.4% | -44.6% | |
| ROIC | -5.9% | -137.3% | -157.4% | -113.9% | -77.0% | · | -37.3% | -44.6% | -38.1% | -55.9% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 | 9.2 | 11.6 | 12.0 | 9.1 | 7.5 | |
| Quick Ratio | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 | 2.5 | 2.1 | 11.9 | 9.1 | 7.4 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | · | 0.0 | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 148.5 | 1326.5 | 14.5 | · | 8.0 | 34.4 | 5.5 | 6.3 | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 153.5% | 298.2% | · | · | -92.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 65.8% | -55.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| Net Income TTM | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| Market Cap | $539M | $118M | $54M | $763M | $1.35B | $2.47B | $7.99B | $6.92B | $10.93B | $2.51B | |
| P/E | -61.8 | -2.4 | -0.7 | -0.7 | -9.3 | -41.0 | -68.2 | · | · | · | |
| P/S | 7.5 | 4.1 | 7.5 | · | 215.1 | 31.2 | 500.8 | 467.5 | 1212.4 | · | |
| P/B | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.3 | 29.3 | 32.9 | 96.7 | 31.5 | |
| P / Tangible Book | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.8 | · | · | · | · | |
| P / Cash Flow | -13.1 | -2.3 | 2.4 | -9.0 | -14.4 | -39.2 | -95.1 | -106.5 | 5878.7 | -72.1 | |
| P / FCF | -13.1 | -2.3 | 2.4 | -9.0 | -13.9 | -38.9 | -93.4 | -106.0 | 10984.2 | -71.8 | |
| Earnings Yield | -1.6% | -42.4% | -136.0% | -148.0% | -10.7% | -2.4% | -1.5% | · | · | · |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $8M | $42M | $11M | $10M | $9M | $7M | $7M | $9M | $6M | $7M | $0 | $0 | $0 | · | · | |
| R&D Expense | $15M | $15M | $17M | $17M | $16M | $15M | $14M | $14M | $16M | $12M | $11M | $11M | $13M | $15M | $17M | $18M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $9M | $4M | $5M | $5M | $6M | $5M | |
| Operating Expenses | $20M | $20M | $23M | $22M | $21M | $19M | $19M | $18M | $21M | $17M | $20M | $15M | $17M | $20M | $23M | $23M | |
| Operating Income | $-6M | $-11M | $20M | $-11M | $-11M | $-10M | $-12M | $-11M | $-12M | $-11M | $-13M | $-15M | $-17M | $-20M | $-23M | $-23M | |
| Other Non-op | $2M | $2M | $2M | $2M | $895.0K | $1M | $1M | $1M | $1M | $2M | $2M | $628.0K | $592.0K | $609.0K | $583.0K | $256.0K | |
| Pretax Income | · | · | $22M | $-9M | $-10M | · | $-10M | $-10M | $-11M | · | $-11M | $-14M | $-17M | · | · | · | |
| Income Tax | · | · | $0 | $0 | $0 | · | $-76.0K | $0 | $406.0K | · | $33.0K | $0 | $0 | · | · | · | |
| Net Income | $-4M | $-9M | $22M | $-9M | $-10M | $-9M | $-10M | $-10M | $-11M | $-9M | $-11M | $-14M | $-17M | $-19M | $-22M | $-23M | |
| EPS (Basic) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| EPS (Diluted) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| Shares (Basic) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| Shares (Diluted) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| EBITDA | $-6M | $-11M | · | $-11M | $-11M | $-10M | · | $-11M | $-12M | $-11M | · | $-15M | $-17M | $-19M | · | $-23M |
Bilan 20
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $31M | $58M | $23M | $24M | $23M | $38M | $28M | $19M | $19M | $20M | $27M | $22M | $43M | $52M | $55M | |
| Receivables | $822.0K | $451.0K | $974.0K | $912.0K | · | · | $0 | $0 | $0 | $43.0K | $43.0K | $0 | $342.0K | $717.0K | $944.0K | $1M | |
| Prepaid Expense | $7M | $6M | $5M | $3M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $6M | $4M | $5M | |
| Current Assets | $328M | $233M | $255M | $237M | $77M | $96M | $116M | $98M | $113M | $117M | $134M | $50M | $64M | $80M | $97M | $115M | |
| PP&E (Net) | $315.0K | $214.0K | $221.0K | $229.0K | $219.0K | $251.0K | $284.0K | $316.0K | $349.0K | $367.0K | $385.0K | $561.0K | $541.0K | $619.0K | $743.0K | $867.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $552.0K | $332.0K | $334.0K | $889.0K | $2M | |
| Total Assets | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Accounts Payable | $1M | $1M | $1M | $2M | $743.0K | $875.0K | $585.0K | $1M | $801.0K | $727.0K | $461.0K | $758.0K | $904.0K | $1M | $2M | $2M | |
| Accrued Liabilities | $3M | $3M | $8M | $6M | $3M | $2M | $7M | $5M | $4M | $2M | $6M | $4M | $4M | $3M | $7M | $6M | |
| Current Liabilities | $23M | $35M | $49M | $53M | $47M | $47M | $48M | $42M | $41M | $39M | $39M | $7M | $9M | $10M | $16M | $15M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $113.0K | $451.0K | $791.0K | $1M | $50.0K | $64.0K | $80.0K | $101.0K | $918.0K | |
| Total Liabilities | $25M | $37M | $51M | $57M | $63M | $72M | $86M | $74M | $81M | $87M | $96M | $10M | $12M | $13M | $19M | $19M | |
| Common Stock | $20.0K | $16.0K | $16.0K | $16.0K | $8.0K | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $53.0K | $52.0K | $52.0K | $4.0K | $48.0K | |
| Retained Earnings | $-845M | $-841M | $-832M | $-854M | $-845M | $-835M | $-826M | $-816M | $-806M | $-795M | $-786M | $-775M | $-760M | $-743M | $-725M | $-702M | |
| AOCI | $-623.0K | $-368.0K | $-41.0K | $-90.0K | $-279.0K | $-253.0K | $-211.0K | $-156.0K | $-293.0K | $-239.0K | $-81.0K | $-275.0K | $-325.0K | $-513.0K | $-803.0K | $-999.0K | |
| Stockholders' Equity | $306M | $199M | $207M | $183M | $18M | $27M | $33M | $26M | $35M | $33M | $41M | $42M | $55M | $70M | $83M | $102M | |
| Liabilities + Equity | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Shares Outstanding | 19,850,342 | 15,892,353 | 15,855,329 | 15,816,987 | 7,672,249 | 7,618,885 | 7,457,240 | 6,354,414 | 6,345,561 | 5,482,752 | 5,482,752 | 52,614,194 | 52,450,731 | 52,015,268 | 4,074,552 | 48,481,194 |
Flux de trésorerie 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20.0K | $26.0K | $32.0K | $32.0K | $32.0K | $33.0K | $32.0K | $33.0K | $32.0K | $32.0K | $84.0K | $116.0K | $126.0K | $124.0K | $124.0K | $134.0K | |
| Stock-based Comp | $2M | $1M | $1M | $2M | $834.0K | $712.0K | $751.0K | $797.0K | $833.0K | $739.0K | $959.0K | $1M | $1M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-700.0K | $800.0K | |
| Other Non-cash | · | $-14M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $14M | $-15M | $-17M | $-23M | $-407.0K | $-15M | $-17M | $-18M | $74M | $-14M | $-14M | $-23M | $-19M | $-20M | |
| CapEx | $0 | $19.0K | $24.0K | $42.0K | $0 | $0 | $0 | $0 | $14.0K | $14.0K | $71.0K | $136.0K | $48.0K | $0 | $0 | $102.0K | |
| Investing Cash Flow | $-92M | $-5M | $21M | $-158M | $17M | $7M | $-7M | $24M | $5M | $17M | $-90M | $19M | $-8M | $10M | $17M | $31M | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $2M | $2M | $0 | $0 | $0 | $0 | $0 | $54.0K | $4M | $325.0K | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $2M | · | · | · | $0 | · | · | · | $4M | · | · | |
| Financing Cash Flow | $109M | $149.0K | $456.0K | $172M | $357.0K | $2M | $17M | $0 | $12M | $0 | $9M | $0 | $134.0K | $4M | $437.0K | $0 | |
| Net Change in Cash | $1M | $-27M | $36M | $-1M | $593.0K | $-15M | $10M | $9M | $459.0K | $-1M | $-7M | $5M | $-22M | $-9M | $-2M | $12M | |
| Free Cash Flow | · | $-22M | · | · | · | $-23M | · | · | · | $-18M | · | · | · | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -47.4% | -138.4% | · | -100.9% | -115.2% | -105.5% | · | -160.1% | -143.0% | -185.5% | · | · | · | · | · | · | |
| Net Margin | -28.8% | -110.5% | · | -85.2% | -105.9% | -93.6% | · | -140.4% | -130.7% | -156.9% | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | -85.2% | -105.9% | · | · | -140.4% | -125.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -47.4% | -138.1% | · | -100.9% | -115.2% | -105.2% | · | -160.1% | -143.0% | -184.9% | · | · | · | · | · | · | |
| ROA | -1.9% | -5.4% | · | -5.4% | -10.4% | -8.1% | · | -12.7% | -12.3% | -8.9% | · | -16.7% | -16.1% | -15.4% | · | -12.5% | |
| ROE | -2.4% | -8.0% | · | -8.8% | -38.6% | -29.5% | · | -28.4% | -24.9% | -17.6% | · | -20.0% | -18.9% | -17.5% | · | -14.1% | |
| ROIC | · | · | · | -6.0% | -61.3% | · | · | -42.1% | -36.5% | · | · | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.0 | 6.6 | · | 4.4 | 1.6 | 2.0 | · | 2.4 | 2.7 | 3.0 | · | 7.0 | 7.3 | 8.0 | · | 7.4 | |
| Quick Ratio | 1.4 | 0.9 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.5 | 0.5 | · | 3.7 | 2.5 | 4.4 | · | 3.6 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | · | · | |
| Receivables Turnover | 32.5 | 33.3 | · | 23.7 | · | · | · | · | 49.9 | 15.2 | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $38M | · | $37M | $34M | $31M | · | $21M | $14M | $6M | · | · | · | · | · | · | |
| Net Income TTM | $-32M | $-37M | · | $-38M | $-40M | $-39M | · | $-44M | $-52M | $-59M | · | $-73M | $-83M | $-90M | · | $-90M | |
| Market Cap | $545M | $441M | · | $405M | $139M | $73M | · | $96M | $87M | $73M | · | $562M | $724M | $524M | · | $954M | |
| P/E | -9.8 | -7.4 | · | -5.4 | -3.0 | -1.5 | · | -1.8 | -1.3 | -1.0 | · | -0.9 | -1.5 | -1.7 | · | -10.5 | |
| P/S | 13.0 | 11.6 | · | 11.0 | 4.0 | 2.4 | · | 4.5 | 6.1 | 12.6 | · | · | · | · | · | · | |
| P/B | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Tangible Book | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Cash Flow | · | -20.0 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | -22.4 | · | · | |
| P / FCF | · | -19.9 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | · | · | · | |
| Earnings Yield | -10.2% | -13.6% | · | -18.5% | -33.1% | -66.1% | · | -55.8% | -78.8% | -99.9% | · | -113.4% | -67.6% | -58.8% | · | -9.6% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $72M | $29M | $7M | $0 | $6M |
| Marge d'exploitation % | -16.8% | -159.3% | -902.5% | — | -2121.7% |
| Résultat net | $-6M | $-40M | $-61M | $-93M | $-130M |
| BPA dilué | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 |
| Ratio de liquidité réduite | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-41M | $-51M | $22M | $-85M | $-96M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 98 déclarants · $481.1M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 40 (+27 vs T. préc.) | 13 (+4 vs T. préc.) | 29 (0 vs T. préc.) | 18 (+4 vs T. préc.) | +5.4M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | $136 770 406 | 4 977 089 | 28,43% | Actions |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $44 094 133 | 1 604 590 | 9,17% | Actions |
| Paradigm Biocapital Advisors LP | $42 696 995 | 1 553 748 | 8,88% | Actions |
| Commodore Capital LP | $38 884 200 | 1 415 000 | 8,08% | Actions |
| RA CAPITAL MANAGEMENT, L.P. | $28 040 867 | 1 020 410 | 5,83% | Actions |
| JANUS HENDERSON GROUP PLC | $23 479 147 | 849 309 | 4,88% | Actions |
| Parkman Healthcare Partners LLC | $19 818 054 | 721 181 | 4,12% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $15 359 726 | 558 942 | 3,19% | Actions |
| Point72 Asset Management, L.P. | $12 657 096 | 460 593 | 2,63% | Actions |
| MILLENNIUM MANAGEMENT LLC | $8 211 216 | 298 807 | 1,71% | Actions |
| Schonfeld Strategic Advisors LLC | $6 654 363 | 242 153 | 1,38% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $6 595 964 | 239 963 | 1,37% | Actions |
| AMERIPRISE FINANCIAL INC | $6 320 400 | 230 000 | 1,31% | Actions |
| DV EQUITIES, LLC | $6 221 884 | 226 415 | 1,29% | Actions |
| Aberdeen Group plc | $5 689 652 | 207 047 | 1,18% | Actions |
| Seven Fleet Capital Management LP | $5 680 995 | 206 732 | 1,18% | Actions |
| Affinity Asset Advisors, LLC | $5 221 200 | 190 000 | 1,09% | Actions |
| B Group, Inc. | $4 828 401 | 175 706 | 1,00% | Actions |
| STATE STREET CORP | $4 724 664 | 171 931 | 0,98% | Actions |
| STEMPOINT CAPITAL LP | $4 681 987 | 170 378 | 0,97% | Actions |
| Squadron Capital Management LLC | $4 396 800 | 160 000 | 0,91% | Actions |
| Woodline Partners LP | $4 143 434 | 150 780 | 0,86% | Actions |
| Driehaus Capital Management LLC | $4 122 000 | 150 000 | 0,86% | Actions |
| Ally Bridge Group (NY) LLC | $3 847 200 | 140 000 | 0,80% | Actions |
| GOLDMAN SACHS GROUP INC | $3 359 155 | 122 240 | 0,70% | Actions |
| FRANKLIN RESOURCES INC | $3 110 736 | 113 200 | 0,65% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 504 884 | 91 153 | 0,52% | Actions |
| VANGUARD GROUP INC | $2 269 895 | 66 742 | 0,47% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $2 032 696 | 73 970 | 0,42% | Actions |
| HighVista Strategies LLC | $2 017 170 | 73 405 | 0,42% | Actions |
| Qube Research & Technologies Ltd | $1 414 890 | 51 488 | 0,29% | Actions |
| MONIMUS CAPITAL MANAGEMENT, LP | $1 307 498 | 47 580 | 0,27% | Actions |
| Trexquant Investment LP | $1 254 764 | 45 661 | 0,26% | Actions |
| XTX Topco Ltd | $1 179 387 | 42 918 | 0,25% | Actions |
| JPMORGAN CHASE & CO | $1 126 389 | 41 780 | 0,23% | Actions |
| MORGAN STANLEY | $1 116 705 | 40 637 | 0,23% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $1 083 839 | 39 441 | 0,23% | Actions |
| BlackRock, Inc. | $980 926 | 35 696 | 0,20% | Actions |
| Squarepoint Ops LLC | $940 201 | 34 214 | 0,20% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $800 437 | 29 128 | 0,17% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $665 098 | 24 203 | 0,14% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $653 062 | 23 765 | 0,14% | Actions |
| Caption Management, LLC | $627 341 | 22 829 | 0,13% | Actions |
| ADAR1 Capital Management, LLC | $561 884 | 20 447 | 0,12% | Actions |
| Palumbo Wealth Management LLC | $545 891 | 19 865 | 0,11% | Actions |
| CITADEL ADVISORS LLC | $508 380 | 18 500 | 0,11% | Option d'achat |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $502 884 | 18 300 | 0,10% | Option de vente |
| TWO SIGMA INVESTMENTS, LP | $490 738 | 17 858 | 0,10% | Actions |
| Engineers Gate Manager LP | $488 210 | 17 766 | 0,10% | Actions |
| Eversept Partners, LP | $453 695 | 16 510 | 0,09% | Actions |
| Susquehanna Portfolio Strategies, LLC | $415 745 | 15 129 | 0,09% | Actions |
| Cubist Systematic Strategies, LLC | $413 716 | 16 161 | 0,09% | Actions |
| Virtus Investment Advisers, LLC | $391 617 | 14 251 | 0,08% | Actions |
| AMERICAN CENTURY COMPANIES INC | $363 808 | 13 239 | 0,08% | Actions |
| RHUMBLINE ADVISERS | $318 486 | 11 590 | 0,07% | Actions |
| Integrated Quantitative Investments LLC | $276 943 | 10 078 | 0,06% | Actions |
| CITADEL ADVISORS LLC | $271 942 | 9 896 | 0,06% | Actions |
| DEUTSCHE BANK AG\ | $264 220 | 9 615 | 0,05% | Actions |
| BANK OF AMERICA CORP /DE/ | $262 901 | 9 567 | 0,05% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $239 076 | 8 700 | 0,05% | Option d'achat |
| Bank of New York Mellon Corp | $234 075 | 8 518 | 0,05% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $233 580 | 8 500 | 0,05% | Actions |
| EntryPoint Capital, LLC | $227 672 | 8 285 | 0,05% | Actions |
| WELLS FARGO & COMPANY/MN | $226 792 | 8 253 | 0,05% | Actions |
| Brevan Howard Capital Management LP | $213 382 | 7 765 | 0,04% | Actions |
| Persistent Asset Partners Ltd | $190 766 | 6 942 | 0,04% | Actions |
| MetLife Investment Management, LLC | $161 720 | 5 885 | 0,03% | Actions |
| BARCLAYS PLC | $140 314 | 5 106 | 0,03% | Actions |
| Vanguard Global Advisers, LLC | $126 820 | 4 615 | 0,03% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $124 182 | 4 519 | 0,03% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $115 416 | 4 200 | 0,02% | Actions |
| MARSHALL WACE, LLP | $111 184 | 4 046 | 0,02% | Actions |
| CITIGROUP INC | $109 508 | 3 985 | 0,02% | Actions |
| Invesco Ltd. | $107 969 | 3 929 | 0,02% | Actions |
| Nuveen, LLC | $100 824 | 3 669 | 0,02% | Actions |
| Police & Firemen's Retirement System of New Jersey | $79 884 | 2 907 | 0,02% | Actions |
| NORTHERN TRUST CORP | $42 512 | 1 547 | 0,01% | Actions |
| Legal & General Group Plc | $26 326 | 958 | 0,01% | Actions |
| Ameritas Investment Partners, Inc. | $24 595 | 895 | 0,01% | Actions |
| Russell Investments Group, Ltd. | $21 654 | 788 | 0,00% | Actions |
| HSBC HOLDINGS PLC | $17 104 | 16 935 | 0,00% | Actions |
| Tower Research Capital LLC (TRC) | $14 564 | 530 | 0,00% | Actions |
| ROYAL BANK OF CANADA | $12 000 | 440 | 0,00% | Actions |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7 145 | 260 | 0,00% | Actions |
| Accent Capital Management, LLC | $5 826 | 212 | 0,00% | Actions |
| Sterling Capital Management LLC | $5 469 | 199 | 0,00% | Actions |
| Truvestments Capital LLC | $5 304 | 193 | 0,00% | Actions |
| FMR LLC | $4 891 | 178 | 0,00% | Actions |
| Integrated Wealth Concepts LLC | $2 968 | 108 | 0,00% | Actions |
| OSAIC HOLDINGS, INC. | $2 748 | 100 | 0,00% | Actions |
| Quarry LP | $2 061 | 75 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $2 061 | 75 | 0,00% | Actions |
| EverSource Wealth Advisors, LLC | $1 511 | 55 | 0,00% | Actions |
| GSA CAPITAL PARTNERS LLP | $1 180 | 42 931 | 0,00% | Actions |
| UBS Group AG | $550 | 20 | 0,00% | Actions |
| Point72 Europe (London) LLP | $332 | 13 | 0,00% | Actions |
| Allworth Financial LP | $275 | 10 | 0,00% | Actions |
| PRICE T ROWE ASSOCIATES INC /MD/ | $226 | 8 203 | 0,00% | Actions |
Initiés de la société 34 initiés · 14 dirigeants · 16 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jason A Okazaki | CEO and President | 29 mars 2026 A | 163 354 | 0 | 0 | $0 |
| Samar Michael P. | Chief Financial Officer | 25 juillet 2022 S | 77 228 | 0 | 0 | $0 |
| Thomas Joseph Russo | CFO | 29 mars 2021 A | 54 633 | 0 | 0 | $0 |
| Graham K Cooper | Chief Financial Officer and Chief Operating Officer | 29 mars 2019 A | 117 500 | 0 | 0 | $0 |
| Jeanette M Bjorkquist | PFO and PAO | 17 juin 2026 S | 14 560 | 0 | 3 | $-9 429 |
| Anuj Gaggar | Chief Medical Officer | 29 mars 2026 A | 42 688 | 0 | 0 | $0 |
| Nicole S White | Chief Manufacturing Officer | 29 mars 2026 A | 48 145 | 0 | 2 | $-5 257 |
| William E Delaney IV | Chief Scientific Officer | 29 mars 2026 A | 60 330 | 0 | 0 | $0 |
| Luisa M Stamm | Chief Medical Officer | 29 mars 2022 A | 40 315 | 0 | 0 | $0 |
| Jacqueline Sybil Papkoff | SVP-CSO Microbiome | 14 décembre 2020 S | 37 364 | 0 | 0 | $0 |
| Richard James Colonno | EVP & CSO, Virology Ops | 27 mars 2020 A | 137 009 | 0 | 0 | $0 |
| Uri A Lopatin | Chief Medical Officer | 29 mars 2019 A | 627 361 | 0 | 0 | $0 |
| Thomas E Rollins | Chief Development Officer | 29 mars 2018 A | 3 750 | 0 | 0 | $0 |
| Thomas Andrew Rowland | Chief Business Officer | 15 janvier 2012 A | — | 0 | 0 | $0 |
| Michael Houghton | Administrateur | 4 juin 2026 A | 3 202 | 0 | 0 | $0 |
| Lisa Johnson-Pratt | Administrateur | 4 juin 2026 A | — | 0 | 0 | $0 |
| John G Mchutchison | Administrateur | 4 juin 2026 A | 18 347 | 0 | 0 | $0 |
| Gina Consylman | Administrateur | 4 juin 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Administrateur | 4 juin 2026 A | — | 0 | 0 | $0 |
| Anthony E Altig | Administrateur | 4 juin 2026 A | 40 000 | 0 | 0 | $0 |
| William R Ringo | Administrateur | 5 juin 2025 A | 17 465 | 0 | 0 | $0 |
| Richard D Dimarchi | Administrateur | 25 mai 2022 A | — | 0 | 0 | $0 |
| Myron Z Holubiak | Administrateur | 20 mai 2021 A | — | 0 | 0 | $0 |
| Helen Kim | Administrateur | 11 juin 2020 A | — | 0 | 0 | $0 |
| Alan Lewis | Administrateur | 11 juin 2020 A | — | 0 | 0 | $0 |
| Derek A Small | Administrateur | 2 janvier 2020 A | 828 791 | 0 | 0 | $0 |
| Mark Auerbach | Administrateur | 17 mai 2019 A | — | 0 | 0 | $0 |
| Russell H Ellison | Administrateur | 10 juillet 2014 A | 21 600 | 0 | 0 | $0 |
| Joseph Felder | Administrateur | 6 mars 2013 A | — | 0 | 0 | $0 |
| Gilead Sciences, Inc. | Détenteur de 10% | 8 août 2025 P | 4 505 391 | 0 | 0 | $0 |
| Alexander Schornstein | Détenteur de 10% | 25 novembre 2024 P | 728 113 | 0 | 0 | $0 |
| EcoR1 Capital Fund Qualified, L.P. | Détenteur de 10% | 17 avril 2018 P | — | 0 | 0 | $0 |
| Adam Zlotnick | Détenteur de 10% | 10 juillet 2014 A | — | 0 | 0 | $0 |
| David Jonathan Barrett | — | 29 mars 2017 A | 19 396 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 3 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. ×5 dépôts | 27 mai 2026 | 25,10% | Amendement | — | SEC |
| Alexander Schornstein ×3 dépôts | 24 juin 2024 | — | Dépôt initial | — | SEC |
| 31 octobre 2023 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 12 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,55% | 7 645 NS | 30 avril 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 33 699 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8 569 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,02% | 88 387 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 56 627 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 9 650 NS | 31 mai 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 240 066 SH | 8 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 6 713 SH | 8 août 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 133 234 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 413 284 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 885 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,00% | 25 072 SH | 8 août 2026 | Quotidien |